At a glance
MACS and IMSI are two different laboratory approaches to choosing sperm for ICSI. Here is what each one does, when clinicians tend to discuss them, and how to compare what a Thai clinic actually offers.
MACS and IMSI are not competing versions of the same step. They work on different problems. IMSI is a way of looking at sperm at very high magnification before injection. MACS is a way of filtering a sperm sample using magnetic labelling to remove cells marked for programmed cell death. Some laboratories use one, some use the other, and some may combine them with ICSI.
That difference matters when you are comparing clinics in Thailand, because the right question is rarely “which is better?” It is closer to: what is being selected for in my case, is there a reason to expect benefit, and can this clinic actually deliver the technique in its own laboratory?
What each technique actually does
IMSI: selection by appearance at high magnification
Intracytoplasmic morphologically selected sperm injection (IMSI) uses magnification far beyond a standard ICSI microscope — often described as around 6000x — so the embryologist can inspect the shape and internal structure of individual sperm before choosing one to inject. The selection criterion is morphological: the sperm looks more normal at high magnification.
IMSI is therefore usually discussed where sperm shape and structure are markedly abnormal, or where a previous cycle produced few usable embryos despite ICSI. It does not change the sperm’s DNA; it changes how carefully the embryologist screens what is visible.
MACS: selection by depleting a marker
Magnetic-activated cell sorting (MACS) passes the sample through a column that binds sperm showing markers associated with apoptosis — the programmed cell death pathway. Sperm carrying such markers are retained, and the unlabelled fraction passes through. The aim is to reduce the proportion of sperm with signs of DNA damage before injection.
MACS is usually raised in conversations about elevated sperm DNA fragmentation or repeated implantation failure, because the rationale is about DNA integrity rather than shape. It is a filtering step, not a visual inspection.
| Question | IMSI | MACS |
|---|---|---|
| What is being selected? | Sperm with more normal morphology at high magnification | Sperm without apoptosis-associated surface markers |
| How is it done? | Microscope-based inspection before ICSI | Magnetic column separation before ICSI |
| Typical discussion context | Severe morphology problems, poor fertilisation or embryo yield after ICSI | High sperm DNA fragmentation, repeated implantation failure |
| Does it replace ICSI? | No — it is a selection step within ICSI | No — it is a selection step within ICSI |
What the evidence does and does not tell you
Both techniques are best understood as refinements of sperm preparation, not as treatments that guarantee a different outcome. The published evidence for routine use is limited, and professional discussion continues about which patients, if any, benefit. Neither technique can promise a pregnancy, a live birth, or a healthy child, and neither corrects sperm DNA problems at the source.
This is also where PGT planning becomes relevant. If you are considering PGT-A, PGT-M or PGT-SR, remember that embryo testing is a separate question from sperm selection. PGT-A assesses chromosome number in cells sampled from an embryo, and testing has limitations — it can produce incorrect findings, and a result does not guarantee a successful pregnancy or a healthy child (HFEA). Embryo biopsy itself carries a risk of damage that can prevent further development (HFEA). Sperm selection choices should be discussed alongside, not instead of, those decisions.
How to compare what a Thai clinic is offering
Clinics differ in whether these techniques are available on site, how often they are performed, and how they are charged. Rather than comparing marketing descriptions, ask for specifics in writing.
- In-house or referred? Is the MACS column or IMSI microscope used in the clinic’s own laboratory, or is the sample sent elsewhere? A referral adds transport and timing considerations.
- Bundled or add-on? Is the technique included in the quoted ICSI cycle price, or charged separately? Ask for the figure in the written quotation, not just verbally.
- Laboratory experience. How many cycles per year involve this technique, and who performs it? Experience with the workflow matters more than the equipment name.
- Indication. Does the clinic recommend it for your specific history, or offer it as an optional upgrade? A recommendation should come with a stated reason.
- Interaction with your plan. If PGT is planned, does the timing or the embryology workflow change?
If you are still at the stage of comparing clinics more broadly, a neutral starting point is our overview of PGT in Thailand, which sets out how testing fits into an IVF cycle. For a wider comparison of providers, the countrywide shortlist research is collected separately; it is an editorial comparison, not a statement about outcomes.
Questions to put to the treating clinician
These are clinical questions, and they belong with the doctor and embryologist responsible for your cycle. A coordinator can help you prepare and transmit them, but cannot diagnose, recommend a technique, or prescribe.
- Given my semen analysis, DNA fragmentation result if available, and treatment history, is there a clinical reason to consider MACS, IMSI, or neither?
- What does the evidence suggest for someone with my profile, and what would you expect it to change?
- What is the additional cost, and is it included in the cycle quotation?
- How often does your laboratory perform this technique, and who will be doing it on the day?
- How does this interact with ICSI, embryo culture, and any planned PGT?
- If we decide against it, what is the alternative plan?
Where coordination helps
The practical work around this decision is mostly administrative: getting your records and prior semen results into one place, asking two or three clinics the same written questions, and keeping track of which answers are confirmed and which are still pending. That is the kind of preparation support described on our contact page — scope and any fees are confirmed individually, and no particular technique or outcome is promised.
Evidence trail
Sources & verification
Review current primary information and reconfirm provider services, fees and eligibility before booking.
01HFEA: Pre-implantation genetic testing for aneuploidy (PGT-A) ↗02HFEA PGT-A frequently asked questions (checked 2026-10-15) ↗Your next practical step
Bring your coordination questions.
Ask about appointments, records, travel or the practical arrangements for your visit.

